MiMedx Group, Inc. (EpiFix and EpiFix Micronized wound care products)
Resolution of NAD referral
Date
By
Mary K. Engle, Associate Director
File
Text of the Letter
(171.59 KB)
Displaying 1921 - 1940 of 3968
Efficiencies Analysis: False Dichotomies, Modeling, and Applications to Health Care
2014 Annual Conference of the American Antitrust Institute
Date
By
Martin S. Gaynor, Former Director, Bureau of Economics
Statement of the Commission, In the Matter of Ardagh Group S.A., Saint-Gobain Containers, Inc., and Compagnie de Saint-Gobain
Date
Matter Number
131 0087
Docket Number
9356
Antitrust Enforcement in Health Care: Proscription, Not Prescription
Date
By
Deborah L. Feinstein, Former Director, Bureau of Competition
File
Prepared Statement of the Federal Trade Commission On Protecting Consumers From False and Deceptive Advertising of Weight-Loss Products
Before the Subcommittee on Consumer Protection, Product Safety, and Insurance of the Committee on Commerce, Science, and Transportation, United States Senate
Washington, DC
Congressional Session
113th Congress
Date
By
Mary K. Engle, Associate Director
File
Text of the Commission Testimony
(90.34 KB)
Blog Post: What's This Charge? How to Protect Yourself From Cramming
Huffington Post
Date
By
Terrell McSweeny, Former Commissioner
The FTC’s Consumer Protection Program: Current Priorities in Advertising and Privacy – Kelley Drye & Warren Privacy and Advertising Law Summit
Date
By
Jessica L. Rich, Former Director, Bureau of Consumer Protection
Remarks of Commissioner Maureen K. Ohlhausen – 2014 Cloud Computing Conference
Washington, D.C.
Date
By
Maureen K. Ohlhausen, Former Commissioner and Former Acting Chair
Profile: FTC’s Brill Emerges as Key Player in National, International Regulation
USA
Date
By
Julie Brill, Former Commissioner
Concurring Statement of Commissioner Joshua D. Wright In the Matter of i-Health, Inc. and Martek Biosciences Corporation
Date
Matter Number
122 3067
By
Joshua D. Wright, Former Commissioner
File
Statement of Chairwoman Edith Ramirez and Commissioner Julie Brill In the Matter of i-Health, Inc. and Martek Biosciences Corporation
Date
Matter Number
122 3067
By
Edith Ramirez, Former Chairwoman;
Julie Brill, Former Commissioner
Separate Statement of Commissioner Maureen K. Ohlhausen Dissenting in Part In the Matter of i-Health, Inc. and Martek Biosciences Corporation
Date
Matter Number
122 3067
By
Maureen K. Ohlhausen, Former Commissioner and Former Acting Chair
Statement of Chairwoman Edith Ramirez and Commissioner Julie Brill In the Matter of i-Health, Inc. and Martek Biosciences Corporation
Date
Matter Number
122 3067
By
Edith Ramirez, Former Chairwoman;
Julie Brill, Former Commissioner
Competition in Health Care Markets: Keynote Address by Julie Brill
Keynote Address, 2014 Hal White Antitrust Conference
Washington, DC
Date
By
Julie Brill, Former Commissioner
File
Prepared Statement of the Federal Trade Commission On S. 2171, The Location Privacy Protection Act of 2014
Before the Subcommittee For Privacy, Technology and the Law of the Committee on the Judiciary, United States Senate
Washington, DC
Congressional Session
113th Congress
Date
Matter Number
P065404
By
Jessica L. Rich, Former Director, Bureau of Consumer Protection
File
Text of the Commission Testimony
(79.84 KB)
Related Releases
Data Brokers: A Call for Transparency and Accountability Opening Remarks of Chairwoman Edith Ramirez
Washington, DC
Date
By
Edith Ramirez, Former Chairwoman
File
Text of the Speech
(25.37 KB)
Supplement to Statement of Commissioner Brill on the Commission’s Data Broker Report
A Call for Transparency and Accountability
Washington, DC
Date
By
Julie Brill, Former Commissioner
File
Statement of Commissioner Brill on the Commission’s Data Broker Report
Data Brokers: A Call for Transparency and Accountability
Washington, DC
Date
Matter Number
P125404
By
Julie Brill, Former Commissioner
File
Text of the Commissioner Statement
(50.14 KB)
Displaying 1921 - 1940 of 3968
Join us at the FTC!